Oruka's psoriasis strategy

Kaveri outlines Oruka's ORKA001, a SkyRisi-like antibody with YTE mutations aiming for once-yearly dosing convenience.

Play episode from 06:55

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!